Edwards Lifesciences Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- S&P 500 ends down after Trump says Iran deal is 'over'
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- GameStop stockholders approve share count increase to 2.5 billion
Edwards Lifesciences (EW) PT Lowered to $145 at Evercore ISI
April 25, 2018 6:40 AM EDTEvercore ISI lowered its price target on Edwards Lifesciences (NYSE: EW) to $145.00 (from $151.00) while maintaining an Outperform rating following results.
... MoreEdwards Lifesciences (EW) Tops Q1 EPS by 10c; Issues Mixed Outlook
April 24, 2018 4:22 PM EDTEdwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.22, $0.10 better than the analyst estimate of $1.12. Revenue for the quarter came in at $938 million versus the consensus estimate of $932.25 million.
GUIDANCE:
Edwards Lifesciences sees FY2018 EPS of $4.50-$4.70, versus the consensus of... More
